Georg M N Behrens Selected Research

Georg M N Behrens Research Topics

Disease

16	COVID-19 10/2022 - 08/2020
11	Infections 01/2022 - 02/2006
5	Inflammation (Inflammations) 12/2012 - 09/2008
4	HIV Infections (HIV Infection) 10/2020 - 04/2003
3	Neoplasms (Cancer) 01/2022 - 05/2004
3	Lipodystrophy 09/2005 - 11/2002
2	Convalescence 01/2022 - 01/2021
2	Chickenpox 12/2017 - 12/2016
2	Measles 12/2017 - 12/2016
2	Rubella (German Measles) 12/2017 - 12/2016
2	Virus Diseases (Viral Diseases) 05/2016 - 06/2004
2	Eosinophilia 12/2012 - 05/2010
2	Mitochondrial Diseases (Mitochondrial Disease) 10/2012 - 01/2010
2	Asthma (Bronchial Asthma) 05/2010 - 09/2008
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2005 - 01/2003
2	Insulin Resistance 09/2005 - 11/2002
1	Anxiety Disorders (Anxiety Disorder) 01/2022
1	Hepatitis 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Skin Neoplasms (Skin Cancer) 01/2022
1	Chronic Renal Insufficiency 08/2021
1	Vesicular Stomatitis 01/2021
1	Hypophosphatemia 01/2021
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Reinfection 01/2021
1	Severe Acute Respiratory Syndrome 12/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2020
1	Syphilis 12/2018
1	Tuberculosis (Tuberculoses) 01/2018
1	Hepatitis A (Hepatitis, Infectious) 08/2017
1	Tetanus 04/2017
1	Diphtheria 04/2017
1	Mumps 12/2016
1	Hepatitis B 05/2016
1	Starvation 01/2014
1	Hepatocellular Carcinoma (Hepatoma) 01/2014
1	Myocardial Infarction 10/2011
1	Respiratory Hypersensitivity 05/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2010

Drug/Important Bio-Agent (IBA)

10	AntibodiesIBA 10/2022 - 08/2017
8	Immunoglobulin G (IgG)IBA 01/2022 - 05/2010
7	AntigensIBA 08/2017 - 06/2004
6	VaccinesIBA 01/2022 - 03/2013
4	Antiviral Agents (Antivirals)IBA 01/2022 - 02/2006
3	bamlanivimabIBA 01/2022 - 01/2021
3	AllergensIBA 12/2012 - 05/2010
3	LipidsIBA 10/2012 - 06/2005
2	Neutralizing AntibodiesIBA 01/2022 - 12/2021
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2017
2	BNT162 VaccineIBA 10/2021 - 01/2021
2	EnzymesIBA 12/2020 - 05/2016
2	Viral AntigensIBA 10/2017 - 11/2011
2	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2012 - 02/2006
1	cilgavimabIBA 10/2022
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 10/2022
1	sotrovimabIBA 10/2022
1	N-(2-cyanoethylene)urea (BA 1)IBA 10/2022
1	COVID-19 VaccinesIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Antitubercular AgentsIBA 01/2022
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2022
1	Monoclonal AntibodiesIBA 10/2021
1	InterferonsIBA 01/2021
1	Caspase 3 (Caspase-3)IBA 01/2021
1	SARS-CoV-2 spike proteinIBA 01/2021
1	Phosphates (Orthophosphate)IBA 01/2021
1	Tenofovir (Viread)FDA Link 01/2021
1	ImmunosorbentsIBA 12/2020
1	hemoglobin ASIBA 10/2020
1	Immunoglobulin A (IgA)IBA 08/2020
1	Adenosine Triphosphate (ATP)IBA 12/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2018
1	Interferon-gamma (Interferon, gamma)IBA 01/2018
1	BilirubinIBA 05/2016
1	Alkaline PhosphataseIBA 05/2016
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 05/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2014
1	Pharmaceutical PreparationsIBA 01/2014
1	salinomycinIBA 01/2014
1	EpitopesIBA 03/2013
1	OvalbuminIBA 12/2012
1	Toll-Like Receptor AgonistsIBA 12/2012
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 12/2012
1	Peptides (Polypeptides)IBA 12/2012
1	abacavir (Ziagen)FDA Link 10/2011
1	CytokinesIBA 05/2010
1	Antigen-Antibody Complex (Immune Complex)IBA 05/2010
1	Mitochondrial DNA (mtDNA)IBA 01/2010
1	Reverse Transcriptase InhibitorsIBA 01/2010
1	NucleosidesIBA 01/2010
1	OligonucleotidesIBA 09/2009
1	Stavudine (Zerit)FDA LinkGeneric 01/2009
1	Immunoglobulin E (IgE)IBA 09/2008

Therapy/Procedure

13	Therapeutics 10/2022 - 04/2003
4	Highly Active Antiretroviral Therapy (HAART) 06/2005 - 11/2002
2	Immunotherapy 01/2021 - 05/2004
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2022
1	Aftercare (After-Treatment) 12/2018
1	Mucosal Administration 12/2012